Mitochondrial disease: A pulmonary and critical-care medicine perspective

Chest

Volumn 120, Issue 2, 2001, Pages 634-648

  Clay, Alison S ^a   Mehrdad, Behnia ^b   Brown, Kevin K ^c  

^a OPW 425   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Critical care; Exercise intolerance; Exercise testing; Hypoventilation; Lactic acidosis; Mitochondria; Mitochondrial genome; Mitochondrial myopathy; Muscle biopsy; Muscle weakness

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; CARNITINE; CELL NUCLEUS DNA; DICHLOROACETIC ACID; LACTIC ACID; MITOCHONDRIAL DNA; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RIBOFLAVIN; TRICARBOXYLIC ACID;

AGING; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSPNEA; EXERCISE TOLERANCE; EXTRACHROMOSOMAL INHERITANCE; FATTY ACID OXIDATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GLYCOLYSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTENSIVE CARE; KEARNS SAYRE SYNDROME; LACTIC ACIDOSIS; LEIGH DISEASE; MUSCLE WEAKNESS; MYOCLONUS EPILEPSY; NEUROLOGIC DISEASE; OPHTHALMOPLEGIA; OUTPATIENT; OXIDATIVE PHOSPHORYLATION; POINT MUTATION; POPULATION GENETIC PARAMETERS; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SLEEP APNEA SYNDROME;

EID: 0034827159     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.2.634     Document Type: Article

References (127)

1. Human mitochondrial diseases: Answering questions and questioning answers
2. Mitochondrial myopathies
3. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease
4. Mitochondria and ageing
5. Mitochondrial function in neuro-degeneration and ageing
6. Mitochondrial defects in basal ganglia diseases
7. Oxidative phosphorylation disease diagnosis
8. The clinical features of mitochondrial myopathy
9. Mitochondrial DNA and disease
10. Seminars in medicine of the Beth Israel Hospital, Boston: Mitochondrial DNA and disease
11. Mitochondrial myopathies
12. Maternal inheritance and the evaluation of oxidative phosphorylation diseases
13. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders
14. Problems with the biochemical diagnosis in mitochondrial (encephalo-)myopathies
15. Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency
16. Lactic acidosis
17. Pathogenesis of lactic acidosis
18. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
19. Defects in mitochondrial fatty acid oxidation: Clinical presentations and their role in sudden infant death
20. Retrospective biochemical screening of fatty acid oxidation disorders in post-mortem livers of 418 cases of sudden death in the first year of life
21. The uncoupling protein, thermogenin
22. Myoclonus epilepsy and ragged-red fibers (MERRF): 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study
23. Lactic acidemia and bradyarrhythmia in a child sedated with propofol
24. Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient
25. Mitochondrial myopathy caused by long-term zidovudine therapy
26. Morphology of the mitochondria in heat shock protein 60 deficient fibroblasts from mitochondrial myopathy patients: Effects of stress conditions
27. Mitochondrial respiratory chain disorders: I. Mitochondrial DNA defects
28. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia
29. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy
30. Rapid segregation of heteroplasmic bovine mitochondria
31. Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNA(Leu(UUR)) mutation associated with maternally inherited myopathy and cardiomyopathy
32. Genetic counseling and prenatal diagnosis for mtDNA disease
33. Mitochondria and heart disease
34. Kearns-Sayre syndrome presenting as renal tubular acidosis
35. Cardiomyopathies in disorders of oxidative metabolism
36. Adult-onset mitochondrial myopathy
37. Late-onset mitochondrial myopathy
38. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA
39. Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency
40. Partial deficiency of complexes I and IV of the mitochondrial respiratory chain in skeletal muscle of two patients with mitochondrial myopathy
41. Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies: Presentation of 19 patients
42. Indications for pacemaker implantation in the Kearns-Sayre syndrome
43. Clinical features associated with the A->G transition at nucleotide 8344 of mtDNA ("MERRF mutation")
44. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA
45. Leber's hereditary optic neuroretinopathy, a maternally inherited disease: A genealogic study in four pedigrees
46. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy
47. Update on hereditary optic neuropathy
48. Clinical, biochemical and molecular genetic features of Leber's hereditary optic neuropathy
49. Clinical spectrum of Leber's hereditary optic neuropathy
50. Redox state and lactate accumulation in human skeletal muscle during dynamic exercise
51. Mitochondrial disease: Pulmonary function, exercise performance, and blood lactate levels
52. Aerobic training benefits patients with mitochondrial myopathies more than other chronic myopathies
53. Effects of aerobic training in patients with mitochondrial myopathies
54. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy
55. Chronic lactic acidosis in an adult: A new syndrome associated with an altered redox state of certain NAD-NADH coupled reactions
56. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy
57. Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat
58. Dinitrophenol poisoning: A diagnosis to consider in undiagnosed fever
59. Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species
60. Systemic absorption of food dye in patients with sepsis
61. Severe lactic acidosis following theophylline overdose
62. Severe hyperlactemia and metabolic acidosis following cocaine use and exertion
63. The management of metformin overdose
64. Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication
65. Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies
66. Respiratory failure revealing mitochondrial myopathy in adults
67. Two cases of mitochondrial myopathy with predominant respiratory dysfunction
68. Depressed ventilatory response in oculocraniosomatic neuromuscular disease
69. Myoclonus, ataxia, and hypoventilation: Response to L-5-hydroxytryptophan
70. Respiratory patterns during sleep in mitochondrial myopathies with ophthalmoplegia
71. Chronic progressive external ophthalmoplegia (CPEO) associated with diaphragm paralysis: Successful treatment with coenzyme Q (CoQ)
72. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy
73. Mitochondria DNA mutations induce variable clinical symptoms including "stroke" in younger and aged persons
74. Stroke, hemiparesis and deficient mitochondrial beta-oxidation
75. Oxidative phosphorylation diseases and stroke
76. OXPHOS defects and mitochondrial DNA mutations in cardiomyopathy
77. Clinical aspects of mitochondrial disorders
78. Acute renal failure and the MELAS syndrome, a mitochondrial encephalomyopathy
79. A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulo-sclerosis as main clinical manifestation
80. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness
81. Mitochondrial deafness
82. Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients
83. Mitochondrial dysfunction in adult-onset myopathies with structural abnormalities
84. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
85. Polysomnographic findings in a patient with the mitochondrial encephalomyopathy NARP
86. Mitochondrial encephalomyopathy, ataxia, and sleep apnea
87. Mitochondrial encephalomyopathy with sleep apnea
88. Sleep and neuromuscular disease: Bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease
89. A mitochondrial myopathy with a defective respiratory chain and carnitine deficiency
90. Disorders of the mitochondrial respiratory chain: Clinical manifestations and diagnostic approach
91. Exercise responses in patients with an enzyme deficiency in the mitochondrial respiratory chain
92. Metabolic myopathies: Evaluation by graded exercise testing
93. An abnormal exercise test response revealing a respiratory chain complex III deficiency
94. Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure
95. Noninvasive evaluation of adult onset myopathy from carnitine palmitoyl transferase II deficiency using proton magnetic resonance spectroscopy
96. Assessment of mitochondrial function and control in normal and diseased states
97. Ragged red or ragged blue fibers
98. Gene shifting: A novel therapy for mitochondrial myopathy
99. Riboflavin-responsive complex I deficiency
100. Therapy of mitochondrial disorders
101. The therapy of respiratory chain encephalomyopathy: A critical review of the past and current perspective
102. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10
103. MELAS (mitochondrial, myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) mtDNA mutation that induces subacute dementia which mimicks Creutzfeldt-Jakob disease
104. Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia
105. Mental disorders in diabetic patients with mitochondrial transfer RNA(Leu) (UUR) mutation at position 3243
106. Mitochondrial DNA in migraine with aura
107. A case of mitochondrial encephalomyopathy with schizophrenic psychosis, dementia and neuroleptic malignant syndrome
108. Endocrine involvement in mitochondrial encephalomyopathy with partial cytochrome c oxidase deficiency
109. Oculocraniosomatic neuromuscular disease with hypopara-thyroidism
110. Neuropathy and mitochondrial myopathy
111. Hereditary motor and sensory neuropathy with optic atrophy: Ultrastructural and morphometric observations on nerve fibers, mitochondria, and dense-cored vesicles
112. Oxidative phosphorylation defect associated with primary adrenal insufficiency
113. Bilateral infantile cataractogenesis in a patient with deficiency of complex I, a mitochondrial electron transport chain enzyme
114. Mitochondrial abnormalities in oculopharyngeal muscular dystrophy
115. Maternally inherited diabetes and deafness (MIDD): A distinct subtype of diabetes associated with a mitochondrial tRNA(Leu)(UUR) gene point mutation
116. Mitochondrial diabetes mellitus
117. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness
118. Endocrine abnormalities in mitochondrial myopathy with external ophthalmoplegia
119. Familial association of metabolic myopathy, lactic acidosis and sideroblastic anemia
120. Acute pancreatitis in an infant with lactic acidosis and a mutation at nucleotide 3243 in the mitochondrial DNA tRNALeu(UUR) gene
121. Lactic acidosis and other mitochondrial disorders
122. Pearson's marrow-pancreas syndrome: A multisystem mitochondrial disorder in infancy
123. Chronic intestinal pseudoobstruction with myopathy and ophthalmoplegia: A muscular biochemical study of a mitochondrial disorder
124. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder
125. Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathy
126. Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA
127. Hereditary glomerulopathy associated with a mitochondrial tRNA(Leu) gene mutation